2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
16
Prostatic Neoplasms
4
Neoplasms
4
Carcinoma, Intraductal, Noninfiltrating
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Peripheral Nervous System Diseases
2
Pain
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Breast Carcinoma In Situ
2
Arthralgia
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Smoldering Multiple Myeloma
1
Sarcoma
1
Radiation Injuries
1
Psoriasis
1
Polyps
1
Polycystic Ovary Syndrome
1
Pelvic Inflammatory Disease
1
Ovarian Neoplasms
1
Osteoarthritis
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Interventions
Colonoscopy
8
Endoscopy
3
Narrow Band Imaging
2
Eicosapentaenoic Acid
2
eicosapentaenoic acid ethyl ester
1
Uterine Myomectomy
1
Ursodeoxycholic Acid
1
Telemedicine
1
Suppositories
1
Sennosides
1
Selenium
1
Restraint, Physical
1
Radiotherapy
1
Propofol
1
Polyethylene Glycols
1
Ofloxacin
1
Midazolam
1
Metoclopramide
1
Methods
1
Folic Acid
1
Fentanyl
1
Fatty Acids, Omega-3
1
Everolimus
1
Erythromycin
1
Endoscopic Mucosal Resection
1
Endomet
1
Doxycycline
1
Docosahexaenoic Acids
1
Diet, Fat-Restricted
1
Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polyps
×
Fatty Acids, Omega-3
×
Clear all
NCT03661047
2021-11-17
OMICC
Massachusetts General Hospital
Phase 2
Withdrawn